[go: up one dir, main page]

BE863656A - Agent immunosuppresseur et son procede de preparation - Google Patents

Agent immunosuppresseur et son procede de preparation

Info

Publication number
BE863656A
BE863656A BE184908A BE184908A BE863656A BE 863656 A BE863656 A BE 863656A BE 184908 A BE184908 A BE 184908A BE 184908 A BE184908 A BE 184908A BE 863656 A BE863656 A BE 863656A
Authority
BE
Belgium
Prior art keywords
preparation process
immunosuppressor
agent
immunosuppressor agent
preparation
Prior art date
Application number
BE184908A
Other languages
English (en)
Original Assignee
Katz David H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katz David H filed Critical Katz David H
Publication of BE863656A publication Critical patent/BE863656A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE184908A 1977-02-03 1978-02-03 Agent immunosuppresseur et son procede de preparation BE863656A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (1)

Publication Number Publication Date
BE863656A true BE863656A (fr) 1978-05-29

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
BE184908A BE863656A (fr) 1977-02-03 1978-02-03 Agent immunosuppresseur et son procede de preparation

Country Status (17)

Country Link
US (1) US4191668A (fr)
JP (1) JPS53121943A (fr)
AU (1) AU515181B2 (fr)
BE (1) BE863656A (fr)
CA (1) CA1118347A (fr)
CH (1) CH644521A5 (fr)
DE (1) DE2804457C2 (fr)
DK (1) DK155174C (fr)
FI (1) FI780312A (fr)
FR (1) FR2379287A1 (fr)
GB (1) GB1599454A (fr)
LU (1) LU78997A1 (fr)
MX (1) MX6266E (fr)
NL (1) NL7801220A (fr)
NO (1) NO153419C (fr)
SE (1) SE464616B (fr)
ZA (1) ZA78613B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (fr) * 1981-10-09 1983-04-20 Beecham Group Plc Allergènes modifiés
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US6022544A (en) * 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
CA1309558C (fr) * 1986-05-30 1992-10-27 Quidel Conjugue d-gl, agent therapeutique
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
IE922292A1 (en) * 1991-07-15 1993-01-27 Jolla Pharma Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
US20030044420A1 (en) * 1999-09-24 2003-03-06 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
CA2414076A1 (fr) 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Molecules a plate-forme polyvalentes comprenant un poly(ethylene oxyde) de poids moleculaire eleve

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation

Also Published As

Publication number Publication date
JPS53121943A (en) 1978-10-24
FR2379287B1 (fr) 1980-08-29
DK155174B (da) 1989-02-27
AU3293378A (en) 1979-08-09
NO780366L (no) 1978-08-04
AU515181B2 (en) 1981-03-19
LU78997A1 (fr) 1978-06-21
CA1118347A (fr) 1982-02-16
FR2379287A1 (fr) 1978-09-01
JPH0428689B2 (fr) 1992-05-15
NO153419C (no) 1986-03-19
NL7801220A (nl) 1978-08-07
SE464616B (sv) 1991-05-27
GB1599454A (en) 1981-10-07
MX6266E (es) 1985-02-27
ZA78613B (en) 1978-12-27
SE7801268L (sv) 1978-08-04
US4191668A (en) 1980-03-04
DK155174C (da) 1989-07-10
DE2804457C2 (de) 1984-04-12
CH644521A5 (de) 1984-08-15
DE2804457A1 (de) 1978-08-10
DK49178A (da) 1978-08-04
NO153419B (no) 1985-12-09
FI780312A (fi) 1978-08-04

Similar Documents

Publication Publication Date Title
BE863656A (fr) Agent immunosuppresseur et son procede de preparation
BE857931A (fr) Gel de phospha-alumine et son procede de preparation
BE868571A (fr) Sucreries aerees et leur procede de preparation
BE869632A (fr) Composition anti-mousse et son procede de preparation
BE869163A (fr) Thioethers basiques et leur procede de preparation
BE863872A (fr) Steroides-11 beta-substitues et procede de leur preparation
SE7811240L (sv) Balningsapparat
LU79310A1 (fr) Procede et composition de traitement de chevelure
LU80062A1 (fr) Agents de blocage neuromusculaire et procede de preparation
BE853604A (fr) Vaccin antirabique et son procede de preparation
FR2310747A1 (fr) Ether 1,2,2,2-tetrafluoroethyl-fluoromethylique, son procede de preparation et son application
FR2312258A1 (fr) Lucknomycine et son procede de preparation
FR2303557A1 (fr) Nouvel antibiotique et son procede de preparation
BE872294A (fr) Procede de preparation de 3-iodorifamycine s et de 3-bromorifamycine s
BE868114A (fr) Mercaptoacetylamidobenzoylglycine et procede therapeutique de mucolyse
BE855824A (fr) Nouvel ester de p-hydroxyphenyluree de l'ibuprofene et son procede de preparation
FR2330408A1 (fr) Agent antihemophilique et son procede de preparation
BE853652A (fr) Monocristal de cuivre et son procede de preparation
BE855092A (fr) 3,5,5-trimethylhexanoyl-ferrcene et son procede de preparation
BE869723A (fr) Charge fumigene et son procede de preparation
BE868027A (fr) Nouvelles pyridazinylhydrazones et leur procede de preparation
BE864401A (fr) Nouvel antibiotique et son procede de preparation
LU79579A1 (fr) Nouvelles pyranoquinoleinones et procede de preparation
BE862066A (fr) Agents anti-rhinovirus et procede de leur preparation
FR2319377A1 (fr) Fortimicine c et son procede de preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCRIPPS CLINIC & RESEARCH FOUNDATION

Effective date: 19920228